LD-2 disclosure · 2nd Quarter - Report
SHATTERPROOF
Client
- Name
- SHATTERPROOF
- Description
- Nonprofit organization focused on opioid policy issues.
- Location
- New York · United States of America
Registrant
- Description
- Law firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Implementation of funding provided for in Consolidated Appropriations Act, 2021 (P.L. 116-260) to address substance use disorder; Mainstreaming Addiction Treatment Act (H.R. 1384/S. 445); Medication Access and Training Expansion Act (H.R. 2067/S. 2235); Fiscal Year 2022 appropriations report language regarding substance use disorder treatment; Medicaid Reentry Act of 2021 (H.R. 955/S. 285); Collaborate in an Orderly and Cohesive Manner Act (H.R.5218); Comprehensive Addiction Resources Emergency Act of 2021 (H.R. 6311/S. 3418); Synthetic Opioid Danger Awareness Act (H.R. 2364); FENTANYL Results Act (H.R. 2538/S. 1160).
LobbyistsJULIE NOLAN · LOUIS AGNELLO · ms CASEY CHRISTINE HIGGINS
Covered position (ms CASEY CHRISTINE HIGGINS): Asst to Spkr for Policy and Trade Cnsl, Paul Ryan, Nov 15-Jan 19; Trade Cncl to House Ways & Means, Jan 15-Nov 15; LC to Rep. Paul Ryan, Oct 11-Jan 15; Law Clrk House Budget Comm, Sep 09-May 10.
TargetedSENATE · HOUSE OF REPRESENTATIVES